Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com
SAO PAULO (Reuters) – Brazilian planemaker Embraer’s third-quarter adjusted net profit soared to 1.18 billion reais ($207.30 million) from 167 million reais…
(Reuters) – Bombardier (OTC:BDRBF) said on Thursday its third-quarter revenue rose 12%, helped by strong demand for business jet parts and repairs….
By Echo Wang NEW YORK (Reuters) – Private equity firm Carlyle Group (NASDAQ:CG) posted flat third-quarter profits but beat Wall Street’s estimates…
Investing.com – Playtika (NASDAQ: PLTK) reported third quarter EPS of $0.11, $0.07 worse than the analyst estimate of $0.18. Revenue for the…
Investing.com – Becton Dickinson (NYSE: BDX) reported fourth quarter EPS of $3.81, $0.04 better than the analyst estimate of $3.77. Revenue for…
By Patrick Wingrove (Reuters) – Moderna (NASDAQ:MRNA) reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of…
(Reuters) – Donald Trump’s return to the White House after winning the Nov. 5 U.S. presidential election may reshape American business. Much…
By Amina Niasse and Sriparna Roy (Reuters) – CVS Health (NYSE:CVS) on Wednesday named Steve Nelson, a former UnitedHealth (NYSE:UNH) insurance head,…
Investing.com – Perrigo (NYSE: PRGO) reported third quarter EPS of $0.81, $0.02 worse than the analyst estimate of $0.83. Revenue for the…
